Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Rosacea
ADR ID BADD_A03896
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.02      Skin appendage conditions
23.02.08      Rosaceas
23.02.08.001      Rosacea
Description A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7). | A variant of rosacea. [MeSH]
MedDRA Code 10039218
MeSH ID D012393; D012393; D012393
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acne rosacea | Rosacea | Rosacea-like dermatitis | Rosacea aggravated | Iatrosacea | Steroid rosacea | Acne Rosacea | Phymatous Rosacea | Rosacea, Phymatous | Ocular Rosacea | Rosacea, Ocular | Papulopustular Rosacea | Rosacea, Papulopustular | Erythematotelangiectatic Rosacea | Rosacea, Erythematotelangiectatic | Granulomatous Rosacea | Rosacea, Granulomatous
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01449Metronidazole0.000357%
BADD_D01470Minocycline0.000177%
BADD_D01490Mometasone--
BADD_D01491Mometasone furoate--
BADD_D01567Nilotinib0.000358%
BADD_D01798Pomalidomide0.001640%
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01834Prednisone--
BADD_D01867Propranolol0.000053%
BADD_D01888Quetiapine0.000055%
BADD_D01925Rescinnamine--
BADD_D01951Risperidone0.000242%
BADD_D02031Sitaxentan--
BADD_D02047Sodium oxybate0.000402%
BADD_D02093Sulfasalazine--
BADD_D02105Tacrolimus0.000743%
BADD_D02170Testosterone--
BADD_D02236Tofacitinib0.006799%
BADD_D02254Tramadol--
BADD_D02270Tretinoin--
BADD_D02272Triamcinolone acetonide--
BADD_D02407Upadacitinib0.000530%
BADD_D02450Crisaborole0.001507%
BADD_D02464Fingolimod0.003954%
BADD_D02579Oxymetazoline0.002447%
The 2th Page    First    Pre   2    Total 2 Pages